Happy Birthday to Max Fink!



Happy 102nd birthday to Max Fink, MD!


Max Fink, an icon in our field, is one of the most influential ECT researchers, practitioners and advocates of all time. He has also been a friend and mentor to many of us in the ECT world, and we owe him a great debt of gratitude.
Please join me in wishing him all the best today!



                                         Max Fink, October 2024, with Andrea and Charles Kellner

Comments

  1. David Zilles-WegnerJanuary 16, 2025 at 7:54 AM

    Congratulations and all the best to Max Fink from Germany!

    ReplyDelete
  2. William V McCallJanuary 16, 2025 at 1:04 PM

    We owe Max a debt of gratitude for getting the filed and all of us to this point. Thanks max

    ReplyDelete
  3. FlorianJanuary 18, 2025 at 7:04 AM

    This comment has been removed by the author.

    ReplyDelete
  4. FlorianJanuary 18, 2025 at 11:13 AM

    Happy Birthday with the best wishes!

    Thank you for your huge contribution in making ECT more and more established and accepted.
    Thank you, Charles Kellner, for continuing this valuable work!

    Great picture!

    ReplyDelete
  5. RayFJanuary 19, 2025 at 12:59 PM

    Max, your contributions to ECT and neuropsychiatry have helped and sometimes saved the lives of numerous individuals. You've been a wonderful mentor to many. I vividly recall the sessions you taught when I was a second year medical student!

    ReplyDelete

Post a Comment

Popular posts from this blog

ECT plus Antidepressants: a Review

Out on PubMed, from researchers in Rotterdam, The Netherlands, is this review: Influence of an adjuvant antidepressant on the efficacy of  electroconvulsive  therapy: A systematic review and meta-analysis. Pluijms EM, Kamperman AM, Hoogendijk WJ, Birkenhäger TK, van den Broek WW. Aust N Z J Psychiatry. 2020 Sep 8:4867420952543. doi: 10.1177/0004867420952543. Online ahead of print. PMID:  32900217 Here is the "Conclusion" section from the text: Our results suggest that an adjuvant antidepressant enhances the efficacy of ECT in patients with major depression. Although the included studies had some methodological limitations, effect sizes were consistently small to moderate. We speculate that modern-day controlled trials using adequately dosed TCAs and MAOIs will most likely result in larger effect sizes. From a clinical point of view, we prefer an adjuvant TCA to an adjuvant MAOI, since TCAs are generally safe to use with ECT ( American Psychiatric Association, 2001 ; ...
Read more

Electroconvulsive Therapy Device Litigation: Two LTEs in Psychiatric Services

Image
 Out on PubMed, from American authors are these two LTEs: Electroconvulsive Therapy Device Litigation. Swartz C. Psychiatr Serv. 2025 May 1;76(5):533-534. doi: 10.1176/appi.ps.20250061. PMID:  40308100   =========================================================================== Reply to Swartz. Appelbaum PS. Psychiatr Serv. 2025 May 1;76(5):534. doi: 10.1176/appi.ps.20250090. PMID:  40308097 Here is a letter from Conrad Swartz and a reply from Paul Applebaum about ongoing/pending ECT device manufacturer litigation, perpetrated by the Church of Scientology. A pity that Dr. Applebaum seems to take a slightly antagonistic obsessional/legalistic view, missing the overarching point of the need to protect ECT from scurrilous attacks.
Read more